Future Cannabis Strategy Conference Europe 2021

• Looking at the UK as the world’s leading jurisdiction for the CBD industry to create clear legal and regulatory frameworks
• Analysing the Novel Food authorisation process journey to understand the impact on those faced with challenges
• Committing to the Novel Food authorisation process initiative to ensure quality and safety to the consumer
• Predicting the CBD food and drink landscape post Novel Food Licence to prepare for the future of the cannabis market

• Looking at the current operational markets to understand progress and developments in each
• Breaking down the current cannabis market across Europe and worldwide to measure current market penetration
• Pinpointing the opportunity in Asia Pacific Markets to branch out for global success
• Getting clear on legislations across each country to weigh up the import/export decision making process
• Breaking through legislative challenges cross-market to develop a successful launch plan

• Is it happy days for CBD after the European Court’s “not a narcotic” ruling?
• What can we understand from the CBD regulatory changes in Europe and the UK cross category?
• With regions, countries and continents at different stages of the CBD and legalised marijuana roadmap, is there a better approach we should take to achieve a unified CBD category moving forward?
• How can we develop a more centralised and consolidated approach to CBD and cannabis legalisation so that the category can grow?
• Where are we lacking in collaboration that is affecting the speed at which cannabis can be a widely accepted category?

• Looking at medical needs to provide solutions for people who need the benefits of cannabis
• Raising the right arguments to convince the lawmakers to think differently and pave way for progress
• Pushing for legal developments to allow patients to access cannabis as part of their treatment
• Creating a clear divide between wellness and medical to cater to physiological needs
• Breaking through the mindsets of lawmakers to make new leglislations that have the power to change the course of medicine

• Creating brands that resonate with the consumer to dominate the global cannabis market
• Building on knowledge and opportunity to cater for both the health-conscious consumer and the medical patient
• Coupling unique product formulas with brand activation to become brand leaders in the industry
• Building strong partnerships within the industry to make cannabis products accessible to those in need
• Striving for a more ethical category to build on consumer trust and allow the category to thrive

• Developing a skin care range to focus on consumer trends in wellness across Europe
• Dignifying cosmetic cannabis through product validation to build value in CBD offerings
• Educating the consumer to understand the benefits in the cosmeceutical product line
• Understanding the challenges behind CBD cosmetics to facilitate entrance to new markets
• Defining fair price points to become accessible yet stay true to CBD quality and benefits

R-Biopharm Rhône Ltd.

• Finding opportunity in high quality ingredient cosmetics to offer products that indulge and benefit the consumer
• Pushing for recognition among beauty professionals and platforms to build trust for CBD integration
• Leveraging the success of a brand to create opportunity for growth worldwide
• Delivering products backed by strong messaging to ensure the consumer knows people come before profits
• Facing fierce competition in the CBD space to deliver a unique and much needed brand built for success

Between 2018 and 2019, cannabis licensed producers were in a race to expand their operations to all corners of the world. The COVID-19 pandemic and declining cannabis stock prices in 2020 lead to a major shift in international expansion, prompting cannabis companies to streamline their global strategy to focus on core jurisdictions and product categories. Join industry leaders Bruce Linton and Jonathan Sherman for a lively discussion on changes to the global cannabis landscape and an in-depth look at international market opportunities.

Topics include:

• Investigating a shift in strategy by major cannabis players from being first to market in every jurisdiction, to focusing on core regions
• Evaluating the key global markets major cannabis players are focused on for recreational use and why
• Understanding which regions and cannabis product categories investment dollars are most frequently directed to

• Evaluating the appeal in Cannabis inspired products to different markets globally to impulse the attraction factor
• Using templates from earlier NPD to better build a CBD product development strategy that builds off safer and tried and tested markets
• Hopping around continents to see different perspectives and formulation solutions surrounding regulatory hurdles
• Spotlighting what’s next to hit the market in Minor Cannabinoids to leverage newopportunities
• Understanding the impact of formulation types and regulatory conditions around product development to better cater to market considerations

• Looking at vaping in the Regulatory & Public Affairs Arena – the common issues & challenges?
• Identifying key ‘learnings’ for what may lie ahead in the CBD & Cannabis sectors
• The challenges in building public awareness, understanding and acceptance in new technologies and products
• The challenges in ensuring reasonable and achievable regulatory outcomes
• The opportunities in a post Brexit world?

R-Biopharm Rhône Ltd.

• Learning learned from EVALI
• Product stewardship and collaboration opportunities for industry
• Safety considerations for delivery systems for CBD/THC inhalable products
• Navigation of regulatory requirements and integration of product stewardship for new product development
• Outwaiting the regulatory and governmental barriers to avoid delays when introducing cannabis smoking products to market

Between 2018 and 2019, cannabis licensed producers were in a race to expand their operations to all corners of the world. The COVID-19 pandemic and declining cannabis stock prices in 2020 lead to a major shift in international expansion, prompting cannabis companies to streamline their global strategy to focus on core jurisdictions and product categories. Join industry leaders Bruce Linton and Jonathan Sherman for a lively discussion on changes to the global cannabis landscape and an in-depth look at international market opportunities.

Topics include:

• Investigating a shift in strategy by major cannabis players from being first to market in every jurisdiction, to focusing on core regions
• Evaluating the key global markets major cannabis players are focused on for recreational use and why
• Understanding which regions and cannabis product categories investment dollars are most frequently directed to

• Taking lessons from the US to explore potential for cannabis in consumer markets
• Looking at the opportunities and potential challenges facing consumer goods firms to approach hurdles more effectively
• Drawing on GlobalData’s extensive cannabis research to identify consumer needs, channels of distribution, industry opinions, and case studies of successful products.

• Summarising the outcome of the UN vote on cannabis and how this affects CBD
• Updating on CosIng and permitted types of CBD extracts in cosmetics
• Outlininh EIHA’s low cost compliance option to obtain a coveted novel food license in the UK & EU

• Leveraging two categories to create a unique hybrid of products set for success
• Using CBD infused no and low alcohol to create an authentic adult social experience
• Tapping into emerging trends to satisfy consumer demand and deliver products that delight
• Understanding the potential in premiumisation behind CBD to build a profitable category
• Making CBD a part of the brand’s purpose to better connect with the consumer for a stronger relationship

• Finding opportunity for retail to manoeuvre successfully in a new market
• Leveraging ecommerce to benefit from newly opened doors online
• Nurturing new relationships to build a thriving category
• Pushing for price categories that represent quality
• Building a brand that taps into consumer demands to deliver high quality CBD products

• Understanding the barriers when launching CBD beverages to the market in Europe, in order to identify emerging opportunities
• Finding ways to create and innovate with new products in the CBD space that are legally accepted
• Braving the market as a new entrant in Spain to inaugurate the category and aim for mass market success
• Coupling cannabis elements with trending flavors and ingredients to create products that attract and benefit the consumer

• Looking at the potential of medical cannabis to pave the way as an essential element of the medical and wellness community
• Developing partnerships to prepare for the increasing demand of quality cannabis access to create a reliable cannabis promoted eco-system
• Tapping into niches in need of cannabis to develop portfolios that make high quality products accessible
• Creating opportunities for hemp and cbd in the market to encourage faith from investors

• Is there opportunity outside of the Europe, Canada and the USA?
• In a post-covid climate, should focus for growth be national or international?
• How can we enter new markets when there is no “one rule fits all” in terms of regulation?
• How can we educate consumers on a global scale of the benefits behind the cannabis market?

• Existing regulations in global markets
• Challenges in the global marketplace due to regulations
• Opportunities in the future

• Looking at the financial picture of CBD to foresee the growth in the category long term
• Getting the capital market’s view of the sector to understand the potential in cannabis
• Understanding the patterns emerging in the CBD industry to follow the financial pulling power behind it
• Following the signals in CBD to leverage its relevance globally behind rising shares

Leveraging the growing capital and the belief in the cannabis sector to withstand the challenges from regulatory roadblocks

Putting consumer preference & perception first in products development – foundation for successful new format launches:

• Looking at different consumer profiles & reason-for-usage to understand the best CBD product formats
• Identifying the power of consumer perception to choose the right format for product creation
• Understanding what drives the consumer to try new products to create consumer loyalty and impulse sales
• Drawing from emerging trends in more CBD advanced regions or other active-ingredient-categories to better understand the link between format and sales figures

• Routes for advertising a CBD product in 2021 and how these compare
• Health claims — the key things all CBD brands should know in order to market responsibly
• PR versus advertising — How do these avenues differ?
• ROI: What constitutes as a successful advertising approach and managing expectations
• How to best approach an editor to secure editorial mentions and more

• Looking at the development of the medical market to understand its potential in the UK and Europe
• Understanding the potential in clinics to treat patients with CBD products
• Pushing for social acceptance to use CBD for beneficial and alternative treatments
• Using global scientific expertise to provide a patient-oriented approach for real results
• Using education and certification to drive prescriptions that address priority medical conditions

• Leveraging natural ingredients to up the effects of cannabis enhanced products
• Combining CBD with adaptogens to open doors to better claims on effectiveness
• Riding on existing niches to simplify the daily cannabis product intake routine
• Creating products that deliver promises to build consumer for a more profitable category
• Building a strategy to grow the CBD category and make way for a thriving sector

• Using hemp in innovative formats to offer wellness and balance
• Promoting calm to cure current consumer stresses the natural way
• Making cannabis accessible to consumers to encourage its adoption through daily practices
• Putting nature at the core of the brand to align with consumer demands for companies that care
• Creating a variety of products cross category to accompany the consumer in their quest for a better lifestyle

• Looking at the potential of medical cannabis to pave the way as an essential element of the medical and wellness community
• Developing partnerships to prepare for the increasing demand of quality cannabis access to create a reliable cannabis promoted eco-system
• Tapping into niches in need of cannabis to develop portfolios that make high quality products accessible
• Creating opportunities for hemp and cbd in the market to encourage faith from investors

• Is there opportunity outside of the Europe, Canada and the USA?
• In a post-covid climate, should focus for growth be national or international?
• How can we enter new markets when there is no “one rule fits all” in terms of regulation?
• How can we educate consumers on a global scale of the benefits behind the cannabis market?

• Taking insights from the e-cigarette experience to devise a strategy for success in cannabis cross-category
• Using past lessons to create commercially successful products from evidence-based innovation
• Focussing on majority sales to develop a strategy built around consumer reaction
• Putting quality first to devise therapeutic applications that are built on consumer trust
• Overcoming challenges to launch and succeed in the current cannabinoid market

Putting consumer preference & perception first in products development – foundation for successful new format launches:

• Looking at different consumer profiles & reason-for-usage to understand the best CBD product formats
• Identifying the power of consumer perception to choose the right format for product creation
• Understanding what drives the consumer to try new products to create consumer loyalty and impulse sales
• Drawing from emerging trends in more CBD advanced regions or other active-ingredient-categories to better understand the link between format and sales figures

• Exploring the origins of the “stigma” around the cannabis industry to identify areas for change moving forward
• Tapping into the BLM social movement & the emergence of the “New Optimist” Consumer post-covid-19 to achieve greater market opportunity
• Debating the importance of socially-conscious cannabis & CBD brands to emerge as category leaders and gain higher levels of success